Risk factor
Very poor trading liquidity
Profitability factor
Strong margins and returns
About
PT Siloam International Hospitals Tbk, together with its subsidiaries, provides healthcare services in Indonesia. It also engages in setting up and managing hospitals. The company offers specialist and general medical services, including complex surgical procedures, laboratory services, radiology and imaging services, diagnostic, and emergency services. Its hospitals provide services in the areas of pediatrics, neurology, ENT, general surgery, emergency, nephrology, cardiology, oncology, obstetrics and gynecology, gastroenterology, ophthalmology, pulmonology, internal medicines, orthopedics, urology, anesthesiology, dentistry, dermatology, geriatric and nuclear medicines, pathology, plastic surgery, and psychiatry. The company operates 40 hospitals with 8,450 beds in Sumatra, Java, Bali, Kalimantan, Sulawesi, Nusa Tenggara Timur, Nusa Tenggara Barat, and Bangka. In addition, it engages in trading, development, mining, agriculture, service, land transportation, industry, workshop printing, plantation, forestry, electrical, mechanical, engineering, construction, agribusiness, and real estate businesses; computer programming activities; provision of management consulting, trust, financing, financial entities, retail, professional, and scientific and technical activities; and web portal and/or digital platform business. The company was formerly known as PT Sentralindo Wirasta. PT Siloam International Hospitals Tbk was founded in 1996 and is headquartered in Tangerang, Indonesia.
Company Valuation
Based on key historical and expected multiples, the stock is overvalued relative to its peers. Specifically, the stock is 'expensive' on P/E, neutral on EV/EBITDA, overpr
Target Price
The average target price of SILO.JK is 2862 and suggests 15% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendati
Buy
Sell